The novel MEK inhibitor atebimetinib in combination with modified gemcitabine/nab-paclitaxel led to a 12-month overall ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...

Cancer care is undergoing a quiet but profound transformation, driven by technology, better understanding of disease biology, and a growing emphasis on quality of life.

J&J successfully acquired Halda Therapeutics for $3.05bn integrating Halda’s RIPTAC platform into J&J’s oncology portfolio.

As Novartis turns the calendar on a new year, the Swiss drugmaker is elaborating further on plans for the $23 billion U.S.

Medical professionals are voicing mounting concern over patient safety following the People's Party's proposal to allow the ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

A recent study by the Laboratory for Neuro-Analysis and Imaging (LANAI) at UMass Chan Medical School highlights how subcortical brain structures degenerate in Alzheimer's disease and frontotemporal ...

A few years ago, I had a patient who affectionately went by the name “Pops.” At 85 years young, he was full of life and juggling multiple health issues alongside prostate cancer, yet determined not to ...

The World Health Organization (WHO) today called on countries to make fertility care safer, fairer and more affordable for all in its first-ever global guideline for the prevention, diagnosis and ...